First Time Loading...

IDEAYA Biosciences Inc
NASDAQ:IDYA

Watchlist Manager
IDEAYA Biosciences Inc Logo
IDEAYA Biosciences Inc
NASDAQ:IDYA
Watchlist
Price: 37.53 USD -0.48% Market Closed
Updated: May 29, 2024

IDEAYA Biosciences Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IDEAYA Biosciences Inc
Net Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
IDEAYA Biosciences Inc
NASDAQ:IDYA
Net Income
-$128.9m
CAGR 3-Years
-60%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Income
$6B
CAGR 3-Years
5%
CAGR 5-Years
2%
CAGR 10-Years
4%
Gilead Sciences Inc
NASDAQ:GILD
Net Income
-$959m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Income
$3.8B
CAGR 3-Years
-19%
CAGR 5-Years
-14%
CAGR 10-Years
-2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Income
$4B
CAGR 3-Years
13%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Income
$3.9B
CAGR 3-Years
-1%
CAGR 5-Years
10%
CAGR 10-Years
26%

See Also

What is IDEAYA Biosciences Inc's Net Income?
Net Income
-128.9m USD

Based on the financial report for Mar 31, 2024, IDEAYA Biosciences Inc's Net Income amounts to -128.9m USD.

What is IDEAYA Biosciences Inc's Net Income growth rate?
Net Income CAGR 5Y
-28%

Over the last year, the Net Income growth was -89%. The average annual Net Income growth rates for IDEAYA Biosciences Inc have been -60% over the past three years , -28% over the past five years .